Anika Therapeutics Inc.

Anika Therapeutics develops and commercializes hyaluronic acid‑based solutions for osteoarthritis pain relief and joint regeneration. Its portfolio includes injectables Monovisc, Orthovisc, Cingal and orthopedic regenerative products across the US, Europe, and globally.

Headquarters: United States (USA)

Website: Visit Site 🔗
Type: Corporation

Company Profile

Sector: Manufacturing
Industry: Pharmaceutical Manufacturing

Employees: 288
HQ: Bedford

Unlock the full potential.

Get access to Relative P/E Ratio Valuation Histogram.

Upgrade

Traded Instruments

+ Add Instrument 1

Symbol	Name	Type	Exchange	Currency	ISIN	Status	Actions
ANIK	Anika Therapeutics Inc. Cap: 0.1B	EQUITY	NMS	USD	US0352551081	Active	📈